Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Juanjie Tang, Tanya Novak, Julian Hecker, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
Spyros Chalkias, Charles Harper, Keith Vrbicky, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 14, pp. 1279-1291
Open Access | Times Cited: 571
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh
The Journal of Gene Medicine (2022) Vol. 24, Iss. 7
Open Access | Times Cited: 42
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study
María‐Eugenia Zaballa, Javier Perez‐Saez, Carlos de Mestral, et al.
The Lancet Regional Health - Europe (2022) Vol. 24, pp. 100547-100547
Open Access | Times Cited: 41
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 34
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth
Florian Wimmers, Allison Burrell, Yupeng Feng, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4632-4651.e23
Closed Access | Times Cited: 29
Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies
Danilo Buonsenso, Francesca Cusenza, Lucrezia Passadore, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 18
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 17
Immunological imprinting of humoral immunity to SARS-CoV-2 in children
Alexander C. Dowell, Tara Lancaster, Rachel Bruton, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
The Incidence and Clinical Characteristics of COVID‐19 in Children With IBD During the Omicron Wave: A Single‐Center Experience in China
Rui Li, Peiyu Chen, Huiwen Li, et al.
Gastroenterology Research and Practice (2025) Vol. 2025, Iss. 1
Open Access
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
Marzia Cavalli, Giulia Campoli, Anna Anselmo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Bivalent Omicron-containing Booster Vaccine Against Covid-19
Spyros Chalkias, Charles Harper, Keith Vrbicky, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Do pathogens always evolve to be less virulent? The virulence–transmission trade-off in light of the COVID-19 pandemic
Ádám Kun, András G. Hubai, Adrienn Král, et al.
Biologia Futura (2023) Vol. 74, Iss. 1-2, pp. 69-80
Open Access | Times Cited: 13
Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus
Olga Kurskaya, Elena A. Prokopyeva, Ivan Sobolev, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 934-934
Open Access | Times Cited: 13
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
Aaron Bodansky, Sara E. Vazquez, Janet Chou, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 926-930.e2
Open Access | Times Cited: 20
Children’s SARS-CoV-2 Infection and Their Vaccination
Sneh Lata Gupta, Rohit Tyagi, Atika Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 418-418
Open Access | Times Cited: 9
Timing of general anesthesia for pediatric patients recovering from COVID-19: a prospective cohort study
Dinghuan Zhao, Wei Liu, Zhao Zhang, et al.
BMC Anesthesiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
Edwards Pradenas, Sílvia Marfil, Víctor Urrea, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106457-106457
Open Access | Times Cited: 7
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland
María-Eugenia Zaballa, Javier Perez‐Saez, Carlos de Mestral, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Covid-19 in the UK: policy on children and schools
Deepti Gurdasani, Christina Pagel, Martin McKee, et al.
BMJ (2022), pp. e071234-e071234
Open Access | Times Cited: 9
Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5–11 years and comparison with individuals aged 12–15 years: an observational and historical cohort study
Makoto Yoshida, Yurie Kobashi, Yuzo Shimazu, et al.
European Journal of Pediatrics (2022) Vol. 182, Iss. 1, pp. 123-133
Open Access | Times Cited: 9
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 1
Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection
Maximilian Stich, Louise Benning, Claudius Speer, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 4
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Alina Seidel, Eva‐Maria Jacobsen, Dorit Fabricius, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Lorenza Bellusci, Gabrielle Grubbs, Shaimaa Sait, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top